// App-Quantinova.ai

148 : Risk factors for cow's milk allergy in Europe: EuroPrevall birth cohort

Researchers

Presenter

  • Khaleva E

Principal Investigators

  • Grimshaw KE

  • Reich A

  • Butiene I

  • Clausen M

  • Dubakiene R

  • Fiandor A

  • Fiocchi A

  • Grabenhenrich LB

  • Larco JI

  • Kowalski ML

  • Rudzeviciene O

  • Papadopoulos NG

  • Rosenfeld L

  • Sigurdardottir ST

  • Sprikkelman AB

  • Schoemaker AA

  • Xepapadaki P

  • Mills CE

  • Keil T

  • Beyer K

Medical Centers

  • Experimental Sciences & Human Development in Health Academic Units, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK, Southampton, United Kingdom

  • Department of Dietetics, Salford Royal Foundation Trust, Salford, United Kingdom

  • German Rheumatism Research Centre, Epidemiologic Unit, Berlin, Germany

  • Faculty of Health Sciences, Klaipeda University, Klaipeda, Lithuania

  • Childrens Hospital Iceland, LandspitaliUniversity Hospita, Reykjavik, Iceland

  • Clinic Chest, Allergology and immunology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania

  • Department of Allergy, Hospital La Paz Institute for Health Research, Madrid, Spain

  • Madrid, Spain

  • Division of Allergy, Pediatric Hospital Bambino, Rome, Italy

  • Department of Dermatology, Venerology and Allergology, Charite University Medicine Berlin, Berlin, Germany

  • Dpt. of Infectious Disease Epidemiology, Robert-Koch-Institute, Berlin, Germany

  • Department of Immunology and Allergy, Medical University of Lodz, Lodz, Poland

  • Clinic of Children’s diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania

  • Division of Infection, Inflammation and Respiratory Medicine, University of Manchester, Manchester, United Kingdom,

  • Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

  • Department of Endocrinology, Landspitali University Hospital, Reykjavik, Iceland

  • Department of Pediatric Respiratory Medicine and Allergy,Emma Childrens Hospital/Academic Medical Center, Amsterdam, Netherlands

  • University of Groningen, University Medical Centre Groningen, Beatrix Children's Hospital, Department of Paediatric Pulmonology and Paediatric Allergology, Groningen, The Netherlands

  • ARUK Centre for Epidemiology, CfMR, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom

  • Institute for Social Medicine Epidemiology and Health Economics, Charite - University Medicine Berlin, Berlin, Germany

  • Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany

  • State Institute of Health, Bavarian Health and Food Safety Authority, Bad Kissingen, Germany

Locations

  • United Kingdom

  • Germany

  • Lithuania

  • Ireland

  • Spain

  • Italy

  • Poland

  • Greece

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Anaphylaxis

Biomarkers

  • Immunoglobulin E

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Prospective

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A